Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506

Neuroscience

Volumn 310, Issue , 2015, Pages 549-560

  Overk, C R ^a   Rockenstein, E ^a   Florio, J ^a   Cheng, Q ^a   Masliah, E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bio assay; Classifier; FK506; Neurodegeneration; Statistical pattern recognition; Two photon

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; CALCINEURIN; CALCIUM; TACROLIMUS; TAU PROTEIN; CALCINEURIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM ALTERATION; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME BINDING; FALSE POSITIVE RESULT; FEMALE; IN VIVO STUDY; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS; TRANSGENIC MOUSE; TWO PHOTON MICROSCOPY; WILD TYPE MOUSE; ANIMAL; CLUSTER ANALYSIS; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; PHYSICAL STIMULATION; SOMATOSENSORY CORTEX; VIBRISSA;

ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CALCINEURIN INHIBITORS; CALCIUM SIGNALING; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; PHYSICAL STIMULATION; ROC CURVE; SOMATOSENSORY CORTEX; TACROLIMUS; TAU PROTEINS; VIBRISSAE;

EID: 84944096614     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.08.068     Document Type: Article

References (25)

1. Anandatheerthavarada H.K., Devi L. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Neuroscientist 2007, 13:626-638.
2. Bell A.J., Sejnowski T.J. An information-maximization approach to blind separation and blind deconvolution. Neural Comput 1995, 7:1129-1159.
3. Berridge M.J. Neuronal calcium signaling. Neuron 1998, 21:13-26.
4. Bezprozvanny I. Calcium signaling and neurodegenerative diseases. Trends Mol Med 2009, 15:89-100.
5. Bishop C.M. Pattern recognition and machine learning 2007, Springer, New York City.
6. Busche M.A., Chen X., Henning H.A., Reichwald J., Staufenbiel M., Sakmann B., Konnerth A. Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2012, 109:8740-8745.
7. Busche M.A., Eichhoff G., Adelsberger H., Abramowski D., Wiederhold K.H., Haass C., Staufenbiel M., Konnerth A., Garaschuk O. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008, 321:1686-1689.
8. Devor A., Tian P., Nishimura N., Teng I.C., Hillman E.M., Narayanan S.N., Ulbert I., Boas D.A., Kleinfeld D., Dale A.M. Suppressed neuronal activity and concurrent arteriolar vasoconstriction may explain negative blood oxygenation level-dependent signal. J Neurosci 2007, 27:4452-4459.
9. Pattern classification 2001, John Wiley & Sons Inc., New York. R.O. Duda, P.E. Hart, D.G. Stork (Eds.).
10. Gotz J., Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 2008, 9:532-544.
11. Kuchibhotla K.V., Goldman S.T., Lattarulo C.R., Wu H.Y., Hyman B.T., Bacskai B.J. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 2008, 59:214-225.
12. Kuchibhotla K.V., Wegmann S., Kopeikina K.J., Hawkes J., Rudinskiy N., Andermann M.L., Spires-Jones T.L., Bacskai B.J., Hyman B.T. Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo. Proc Natl Acad Sci U S A 2014, 111:510-514.
13. Makeig S., Bell A.J., Jung T.P., TJ S. Independent component analysis of electroencephalographic data. Adv Neural Inf Process Syst 1996, 8:145-151.
14. Mukamel E.A., Nimmerjahn A., Schnitzer M.J. Automated analysis of cellular signals from large-scale calcium imaging data. Neuron 2009, 63:747-760.
15. Reddy P.H. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res 2011, 1415:136-148.
16. Reznichenko L., Cheng Q., Nizar K., Gratiy S.L., Saisan P.A., Rockenstein E.M., Gonzalez T., Patrick C., Spencer B., Desplats P., Dale A.M., Devor A., Masliah E. In vivo alterations in calcium buffering capacity in transgenic mouse model of synucleinopathy. J Neurosci 2012, 32:9992-9998.
17. Richard J., Constantinidis J., Tissot R. Calcium EDTA treatment of Pick's disease. Nouv Presse Med 1978, 7:1304.
18. Rockenstein E., Mallory M., Hashimoto M., Song D., Shults C.W., Lang I., Masliah E. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 2002, 68:568-578.
19. Rockenstein E., Mallory M., Mante M., Sisk A., Masliaha E. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J Neurosci Res 2001, 66:573-582.
20. Rockenstein E., Nuber S., Overk C.R., Ubhi K., Mante M., Patrick C., Adame A., Trejo-Morales M., Gerez J., Picotti P., Jensen P.H., Campioni S., Riek R., Winkler J., Gage F.H., Winner B., Masliah E. Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain 2014, 137:1496-1513.
21. Rockenstein E., Overk C.R., Ubhi K., Mante M., Patrick C., Adame A., Bisquert A., Trejo-Morales M., Spencer B., Masliah E. A novel triple repeat mutant tau transgenic model that mimics aspects of Pick's disease and fronto-temporal tauopathies. PLoS One 2015, 10:e0121570.
22. Rusnak F., Mertz P. Calcineurin: form and function. Physiol Rev 2000, 80:1483-1521.
23. Stosiek C., Garaschuk O., Holthoff K., Konnerth A. In vivo two-photon calcium imaging of neuronal networks. Proc Natl Acad Sci U S A 2003, 100:7319-7324.
24. Thibault O., Gant J.C., Landfield P.W. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 2007, 6:307-317.
25. Zundorf G., Reiser G. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal 2011, 14:1275-1288.